Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-29Clinical Trial Update: A Study to Compare Eribulin Mesylate + Pertuzumab + Trastuzumab With Paclitaxel or Docetaxel + Pertuzumab + Trastuzumab [Phase 3]
A Phase 3 breast cancer trial comparing eribulin mesylate + pertuzumab + trastuzumab versus paclitaxel or docetaxel + pertuzumab + trastuzum…
-
CLINICAL_TRIALS trial_result · 2025-09-29Clinical Trial Update: Impact of Topical Tranexamic Acid in Breast Reconstruction [Phase 4]
A Phase 4 trial evaluating topical tranexamic acid to reduce bleeding in breast reconstruction was terminated, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-09-29Clinical Trial Update: Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors [NA]
A clinical trial evaluating exercise to target metabolic dysregulation in stage I-III breast and prostate cancer survivors has been terminat…
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: Abemaciclib in Combination With Endocrine Therapy as First Line Therapy in Metastatic Breast Cancer Patients
ClinicalTrials.gov indicates a completed study evaluating abemaciclib in combination with endocrine therapy as first-line treatment for meta…
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: Treatment of Refractory Nausea and Vomiting in Patients With Breast Cancer [Phase 3]
A Phase 3 trial evaluating a treatment for refractory nausea and vomiting in breast cancer patients has completed, with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: Efficacy Study of Ifabond in Breast Cancer Surgery [NA]
This clinical trial update reports the completion of an efficacy study of Ifabond used in breast cancer surgery. Conditions studied include …
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 trial of NKT3447 in adults with advanced or metastatic solid tumors has been terminated. The study encompassed indications including…
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: Neoadjuvant Lenvatinib Combined With Letrozole in Hormone Receptor Positive Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating neoadjuvant lenvatinib combined with letrozole for hormone receptor-positive breast cancer; the study …
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy [NA]
Completed clinical trial evaluating rhomboid intercostal plane block for reducing chronic pain incidence and acute pain scores after mastect…
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: SMS Messaging as a Tool to Improve Cancer Screening Programs [NA]
A completed clinical trial evaluated SMS messaging as a tool to improve participation in cancer screening programs. The study focused on col…
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: Enhancing Cancer Prevention and Control Pathways-Native Health Initiative [NA]
A completed clinical trial update reports results for the Native Health Initiative aimed at improving cancer prevention and control, coverin…
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors [Phase 1, Phase 2]
This clinical trial update describes a trastuzumab-based CAR-T therapy targeting HER2-positive advanced breast cancer and other solid tumors…
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Effect of Dexmedetomidine Infusion on Post Anesthesia Discharge Time [NA]
A completed clinical trial evaluating whether dexmedetomidine infusion affects postoperative discharge time after breast cancer surgery.
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Isolation of Volatile Organic Compounds (VOCs) Related to the Olfactory Signature of Breast Cancer. (KDOGCOV) [NA]
A completed clinical trial sponsored by Institut Curie investigates volatile organic compounds related to the olfactory signature of breast …
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC
This completed clinical trial update analyzes treatment patterns and clinical outcomes of palbociclib combinations in hormone receptor-posit…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC [Phase 1]
A Phase 1 trial named DAPHNe is evaluating the combination of paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer. The st…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: RecurIndex Guided Avoidance of Regional Nodal Irradiation for Node Positive Breast Cancer [NA]
A clinical trial is evaluating RecurIndex-guided avoidance of regional nodal irradiation for node-positive breast cancer, and the study is c…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer [NA]
This ClinicalTrials.gov update notes that the trial evaluating intensity-modulated accelerated partial breast irradiation before surgery in …
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Chlorhydrate of Ropivacaine and Breast Cancer Surgery [Phase 4]
A Phase 4 clinical trial evaluating chlorhydrate of ropivacaine for breast cancer surgery has completed, per sponsor Institut Curie.
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE) [Phase 3]
A Phase 3 trial (SIMRISE) is evaluating SIM0270 in combination with everolimus versus physician's choice in ER+/HER2- advanced/metastatic br…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: A Study of Allogenic Natural Killer Cells in Combination With Trastuzumab and Pertuzumab in Adult Patients With Refractory Metastatic Her2 Positive Breast Cancer. NK-ACT-BC_2020 [Phase 1]
Phase 1 study evaluating allogeneic natural killer cells with trastuzumab and pertuzumab for refractory metastatic HER2-positive breast canc…
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Hydrosorb® Versus Control in the Management of Radio-induced Skin Toxicity: Multicentre Controlled Phase III Randomized Trial [Phase 3]
Phase III randomized trial comparing Hydrosorb to control for radiation-induced skin toxicity in breast cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: ER-One: A Double-blind Trial of Erector Spinae Block (ESP) Versus Paravertebral Block (PVB) Before Breast Cancer Surgery [Phase 4]
Phase 4 double-blind trial comparing erector spinae block (ESP) to paravertebral block (PVB) for anesthesia in breast cancer surgery; the st…
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: MIRs 04 : Interpectoral Nerve Block With Ropivacaine Versus Placebo Before Breast Cancer Surgery [Phase 3]
Phase 3 trial comparing interpectoral nerve block with ropivacaine to placebo in breast cancer surgery has completed. The study evaluated an…
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: TAS102 in Patients With ER-positive, HER2-negative Advanced Breast Cancer [Phase 2]
A Phase 2 study evaluating TAS-102 (trifluridine/tipiracil) in ER-positive, HER2-negative advanced breast cancer is currently active but not…